Sharon Rockmaker was determined to have a Whipple procedure despite having stage IV pancreatic cancer, and she finally did.
Dr. Michael Chuong explains the advantages of radiation treatment with an MRI-guided system for pancreatic cancer patients.
Can targeted radiation disrupt tumor growth in the liver of advanced pancreatic cancer patients with BRCA2 and PALB2 mutations?
Dr. Kim A. Reiss is leading a study of the PARP inhibitor olaparib to delay or prevent a recurrence of surgically removed pancreatic cancer.
Laura Metzger had many different symptoms of pancreatitis and pancreatic cancer but no one put the picture together for years.
Because Helene Avraham-Katz has the BRCA2 mutation, certain chemotherapies work better and she is eligible for specific clinical trials.